CC-Type chemokine receptor 5-Δ32 mutation protects against primary sclerosing cholangitis-Reference-Cited by-同舟云学术

CC-Type chemokine receptor 5-Δ32 mutation protects against primary sclerosing cholangitis

Published:2006-04 Issue:4 Volume:12 Page:272-277
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Henckaerts Liesbet,Fevery Johan,Van Steenbergen Werner,Verslype Chris,Yap Paul,Nevens Frederik,Roskams Tania,Libbrecht Louis,Rutgeerts Paul,Vermeire Séverine

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference24 articles.

1. Primary sclerosing cholangitis

2. Primary sclerosing cholangitis in children: A long-term follow-up study

3. Chemokine receptor CCR5: insights into structure, function, and regulation

4. Identification of a major co-receptor for primary isolates of HIV-1

5. Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis;JCI Insight;2023-06-22

2. Anatomy and Physiology of the Biliary Epithelium;Comprehensive Toxicology;2018

3. Highly specific blockade of CCR5 inhibits leukocyte trafficking and reduces mucosal inflammation in murine colitis;Scientific Reports;2016-08-05

4. Sclerosing Cholangitis in Children and Adolescents;Clinics in Liver Disease;2016-02

5. C-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection;Applied & Translational Genomics;2013-12